Synopsis of recent research by authors named "Kaori Hino"
- Kaori Hino's recent research primarily focuses on the treatment of gastrointestinal cancers, particularly gastric and colorectal cancers, with a combination of novel therapeutics and addressing treatment-related deficiencies such as zinc deficiency in patients undergoing chemotherapy.
- In a phase II study, Hino investigated the efficacy and safety of a liposomal formulation of eribulin combined with nivolumab specifically for gastric cancer, revealing promising preliminary results for the cohort studied.
- Furthermore, Hino conducted a multicenter retrospective study on real-world treatment sequencing for vulnerable patients with metastatic colorectal cancer, contributing valuable insights into treatment outcomes for this patient population.